A block deal involving Rs 706 crore shares of Contract Development Manufacturing Organisation (CDMO) player Syngene International took place on the exchanges on December 10, with promoter Biocon being the likely seller. As much as 82.2 lakh shares, making up a 2 percent stake in Syngene changed hands at an average price of Rs 858.5 apiece, reflecting an over 1 percent discount from Monday's closin...

Let's catch up on the latest news from the stock market. From significant investments to major deals, order wins, and acquisitions, here’s a quick look at which stocks will be in focus in today's trade:Stocks To WatchTata MotorsThe Tata Group company will increase the prices of its cars, including electric vehicles, by up to 3% from January. This move comes as part of a trend among automakers ra...

Top Buy IdeasThe benchmark indices closed a rangebound session on a negative note, continuing the downtrend for the fourth straight day, with an overall weak market breadth. About 1,607 shares declined, while 892 shares advanced on the NSE. The market is expected to remain consolidative with a negative bias. Below are some trading ideas for the near term:Amol Athawale, VP-technical Research at Kot...

The benchmark indices saw profit booking after hitting new highs, closing in the red on July 10, with negative breadth. About 1,640 shares declined, while 694 shares advanced on the NSE. The Nifty 50 failed to sustain 24,400 on a closing basis. If the index breaks 24,200, the immediate support, then selling pressure may extend to 24,000. On the higher side, the resistance is placed at 24,460. Here...

NEW DELHI : Syngene International Ltd reported strong 17% revenue growth for the September quarter. Most segments contributed to this growth. Key client markets in the US and Europe that are in process of returning to normal operations are helping the company’s discovery services segment. The segment demand is also being helped by newer services such as PROTACS and peptide synthesis. The biologi...